NCT02305173View on ClinicalTrials.gov

Dexamethasone and Respiratory Function After Mastectomy

PHASE3CompletedINTERVENTIONAL
Enrollment

120

Participants

Timeline

Start Date

November 30, 2014

Primary Completion Date

November 30, 2015

Study Completion Date

November 30, 2016

Conditions
Respiratory; Disorder, Functional, Impaired
Interventions
DRUG

Intravenous Dexamethasone

One dose of intravenous dexamethasone (8 mg) 60 minutes before surgery.

DRUG

intravenous salin water

Patients of the control group received homologated placebo 60 minutes before surgery.

Trial Locations (1)

Unknown

Research Unit in Clinical Epidemiology, Specialties Hospital. Mexican Institute of Social Security, Guadalajara

All Listed Sponsors
lead

Instituto Mexicano del Seguro Social

OTHER_GOV

NCT02305173 - Dexamethasone and Respiratory Function After Mastectomy | Biotech Hunter | Biotech Hunter